Detalhe da pesquisa
1.
The Microbiological Profile and Antibiotic Susceptibility of Fracture Related Infections in a Low Resource Setting Differ from High Resource Settings: A Cohort Study from Cameroon.
Antibiotics (Basel)
; 13(3)2024 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534671
2.
HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon.
Medicine (Baltimore)
; 102(22): e33897, 2023 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37266631
3.
Implementation and evaluation of a therapeutic patient education programme during a clinical trial in Yaoundé, Cameroon - Trial ANRS-12286/MOBIDIP.
Patient Educ Couns
; 101(7): 1262-1269, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29433950
4.
Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
Lancet HIV
; 4(9): e384-e392, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28566227